Good morning, happy Friday the 13th, and welcome back to Vitals. The Obamacare repeal schedule has gotten trickier, GOP leaders are trying to deal with conflicting demands, CVS will sell a cheaper EpiPen competitor, and it looks like we have another FDA candidate.
Thanks to all of you for giving us your time and attention. We're always trying to perfect what we cover and how we do it, to make it as easy for you as possible, so please keep the feedback and suggestions coming. And tell your favorite smart people to sign up here.